EUropean Group On Graves' Orbitopathy

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


    

 

Constitution of EUGOGO


MISSION STATEMENT

Graves' Orbitopathy is a relatively rare and difficult disease to manage. Many of the treatments have not been subjected to rigorous scientific evaluation. A major obstacle to improving the management of this condition is that no individual centre has access to sufficiently large numbers of patients for adequately powered randomised controlled clinical trials.

EUGOGO was established by European centres which have long experience in managing patients with Graves’ Orbitopathy within a multidisciplinary framework, have a track record in clinical research in this condition, and constitute large regional or national referral centres.

EUGOGO is a consortium of clinicians (endocrinologists and ophthalmologists), clinical epidemiologists and radiologists, committed to improving the management of patients with Graves' Orbitopathy within a multidisciplinary and scientific context.

 

OBJECTIVES

EUGOGO aims to:

·        contribute towards understanding the pathogenesis of  Graves’ Orbitopathy and improving the management of patients, through collaborative scientific basic and clinical research.

·        contribute towards education, teaching and training of health professionals involved in the care of patients with Graves’ Orbitopathy

·         raise funds to support its activities

 

MEMBERSHIP

Membership of other centres will be considered by the Executive Committee (EC), but these generally must demonstrate an interest in Graves’ Orbitopathy, subscribe to the principle of multidisciplinary management of patients, demonstrate compliance with the EUGOGO assessment protocols and be major tertiary referral centres. New centres will submit a formal application to the secretary in a provided proforma. The application will be considered by the EC at the next meeting. The EC will decide to accept or reject an application. Before joining EUGOGO, representatives from  new centres are required to attend one of the EUGOGO teaching courses and to submit CRFs for 10 consecutive patients, in order to ensure competence and uniformity of  clinical assessments. New centres will be granted an initial provisional membership for 2 years. Permanent membership will be granted after provisional membership if the centre is deemed by the EC to have contributed sufficiently to the work of EUGOGO.

Member of the EC who plans to retire or withdraw from EUGOGO should let the Executive Committee know in advance who is to be their replacement and submit a brief outline of that person’s involvement in the centre’s activity. The new member should attend one of the EUGOGO teaching courses, and there should be some overlap (by one meeting) between retirement of one member and replacement by another.

Membership is not open to patients or the general public, although EUGOGO has strong links with patient-led organisations. EUGOGO is independent of financial or other obligations to other organisations including the Pharmaceutical Industry. EUGOGO, through its members has links with national and international professional and academic organisations in the field of Endocrinology and Ophthalmology.

 

EXECUTIVE COMMITTEE

EUGOGO is governed by an Executive Committee comprising representatives from the member centres. Currently each centre has 2-3 representatives in the Executive Committee (generally one ophthalmologist and one endocrinologist). Each member centre may have additional EUGOGO members (approved by the Executive Committee) who are closely involved with EUGOGO business, and who may at times represent their centre in the Executive Committee.

The Executive Committee is led by the Chairman and supported by the Secretary and Treasurer. The Chairman, Secretary and Treasurer’s tenures are 3 years, and a maximum of two terms. The Chairman, Secretary and Treasurer must be nominated and seconded by members of the Executive Committee and are elected by absolute majority. The Chairman’s duty is to represent EUGOGO, organise at least one meeting per annum of the Executive Committee, chair the Executive Committee sessions and communicate with members. It is the Chairman’s duty, in close collaboration with the Treasurer and members of the Executive Committee, to ensure that EUGOGO’s finances are managed appropriately. The Secretary is responsible for keeping and circulating the minutes of the Executive Committee, deal with applications of new membrers and communicate formally with outside agencies. The Treasurer is responsible for the accounts and banking. It is also the Treasurer’s duty to report on EUGOGO’s financies at each Executive Committee meeting and submit a written report at the end of each calendar year. The Treasurer’s annual report will be reviewed by two nominated EUGOGO EC members who will act as auditors.

Non-attendance of member centre representatives in three consecutive meetings of the Executive Committee may lead to suspension of that centre.

The Executive Committee will strive to govern by the principles of consensus. When consensus is impossible, decisions will be made by ballot based on absolute majority, except for changing the constitution when a ¾ majority will be required. Each participating center is allocated two votes. Voting by proxy will not be allowed.

 

 

  2004 - 2011 All rights reserved - eugogo.eu